Pharmacy Plus, a leading pharmaceutical company, has launched Duostam, an advanced treatment for Benign Prostatic Hyperplasia (BPH), also known as prostate enlargement. BPH is a non-cancerous condition involving an increase in the size of the prostate gland due to cellular growth.
At the 97th Pharmaceutical Society of Nigeria Conference in Uyo, Professor Ikenna Nnabugwu highlighted that the prostate is a major contributor to lower urinary tract symptoms (LUTS) in ageing men, with a prevalence of LUTS/BPH reaching approximately 20% in men over 40 years old.
In response to this significant health concern, Pharmacy Plus said the introduced Duostam as a targeted solution for BPH treatment offers numerous benefits, including relief from LUTS, improving quality of life in men with enlarged prostate, and slowing the disease progression.
Read Also:Â Tinubu approves governing councils swap between federal varsities
In addition, the medication also reduced the risk of acute urinary retention and bleeding from an enlarged prostate.
Managing Director of Pharmacy Plus, Chukwuemeka Obi, stated that as a research-driven pharmaceutical company, they are committed to providing effective treatment options for patients. He assured that Duostam is safe for use, with clinical studies confirming its efficacy when used as prescribed.
ALSO READ TOP STORIES FROM NIGERIAN TRIBUNE
and then